Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) EBT Margin (2016 - 2025)

Marimed (MRMD) has disclosed EBT Margin for 15 consecutive years, with 17.59% as the latest value for Q4 2025.

  • Quarterly EBT Margin fell 908.0% to 17.59% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.67% through Dec 2025, down 413.0% year-over-year, with the annual reading at 6.8% for FY2025, 409.0% down from the prior year.
  • EBT Margin for Q4 2025 was 17.59% at Marimed, down from 0.45% in the prior quarter.
  • The five-year high for EBT Margin was 35.01% in Q2 2021, with the low at 24.76% in Q4 2023.
  • Average EBT Margin over 5 years is 4.25%, with a median of 1.76% recorded in 2021.
  • The sharpest move saw EBT Margin soared 5351bps in 2021, then plummeted -3245bps in 2023.
  • Over 5 years, EBT Margin stood at 2.47% in 2021, then surged by 211bps to 7.69% in 2022, then tumbled by -422bps to 24.76% in 2023, then skyrocketed by 66bps to 8.51% in 2024, then plummeted by -107bps to 17.59% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 17.59%, 0.45%, and 1.46% for Q4 2025, Q3 2025, and Q2 2025 respectively.